Product Description
A lotion by Ortho Dermatologics for Atopic Dermatitis.
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Bausch Health Americas
Company Location: QUEBEC A8 H7L 4A8
Company CEO: Thomas J. Appio
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Dermatitis, Atopic
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| V01-124A-302 | P3 |
Completed |
Dermatitis, Atopic |
2020-05-12 |
22% |
2023-05-09 |
Primary Endpoints|Treatments |
| V01-124A-301 | P3 |
Completed |
Dermatitis, Atopic |
2020-04-14 |
22% |
2023-05-09 |
Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
06/10/2021 |
News Article |
Global Atopic Dermatitis Pipeline Insight Research Report 2021 - ResearchAndMarkets.com |